Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 69   

Articles published

GSK 1,474.62 -3.88 (-0.26%)
price chart
Glaxo CEO Says Europe Market 'Much' Worse Than Expected
GlaxoSmithKline Plc Chief Executive Officer Andrew Witty said, �What we've seen in the last three, four months is a much higher level of price pressure than we had anticipated, which is of course making short-term trading more challenging than expected.
Related articles »  
GSK Receives FDA Approval for MenHibrix�
PHILADELPHIA, June 14, 2012 /PRNewswire/ -- GlaxoSmithKline plc (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the vaccine MenHibrix� [Meningococcal Groups C and Y and Haemophilus b Tetanus ...
US approves Glaxo meningitis vaccine for children  Fox News
Related articles »  
Glaxo Gene-Blocking Melanoma Drugs Beat Chemotherapy in Studies
Two experimental GlaxoSmithKline Plc (GSK) drugs that block genes tied to lethal skin cancer worked better than chemotherapy in studies that tested them individually, paving the way for final-phase trials on their use together.
A Drug for Advanced Melanoma Is Found to Prolong Patients' Lives  New York Times
Related articles »  
KineMed Announces Biomarker Discovery Collaboration with GSK
EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. (www.kinemed.com) announced today a multi-year R&D collaboration with GlaxoSmithKline plc (GSK) (LSE: GSK, NYSE: GSK) that will apply KineMed's proprietary biomarker discovery platform in ...
Related articles »  
Glaxo, Xenoport's drug gets FDA nod for new use
(Reuters) - Drugmaker XenoPort Inc and partner GlaxoSmithKline Plc said the U.S. Food and Drug Administration had approved their drug to treat shingles-related nerve pain.
FDA Approves Postherpetic Neuralgia Treatment  Z6Mag
FDA Approves Drug for Treating Restless Leg Syndrome  TopNews New Zealand
Related articles »  
Glaxo, Novartis to get US contracts to make vaccines
WASHINGTON (Reuters) - Pharmaceutical companies including GlaxoSmithKline PLC and Novartis AG will get federal money to help develop medicines against pandemics and bioterrorist threats, the U.S.
Related articles »  
US top court rules for Glaxo on overtime pay
By a 5-4 vote, the high court handed a defeat to two former sales representatives for a unit of Britain's GlaxoSmithKline Plc. They had appealed a U.S. appeals court in California ruling that they were "outside sales" personnel exempt from federal ...
Related articles »  
Investment For Beginners: Archive
Our series on investment for beginners takes you through the steps of getting started with shares. So, you think you might like to invest in shares, but you're stuck at the first hurdle thinking: "Yes, but what do I actually do?
FDA approves XenoPort, GSK's Horizant ER tablets for management of PHN
GlaxoSmithKline plc (GSK) and XenoPort, Inc. (Nasdaq:XNPT) announced today that the United States (US) Food and Drug Administration (FDA) has approved Horizant� (gabapentin enacarbil) Extended-Release Tablets for the management of postherpetic ...
Related articles »  
U.K. Stocks Rise; FTSE 100 Gains 0.4%, BAT, Glaxo Advance
Among the stocks in the index, 76 rose, 23 fell and three were unchanged. Gains in the FTSE 100 were led by British American Tobacco Plc and GlaxoSmithKline Plc. To contact the editor responsible for this story: Alan Soughley at asoughley@bloomberg.net.
Related articles »